Tag: medical malpractice

  • Life Care Planning Expert Witness Allowed to Testify Despite Her Limited Experience with Pediatric Patients

    Life Care Planning Expert Witness Allowed to Testify Despite Her Limited Experience with Pediatric Patients

    On July 29, 2022, a minor, Kamila, represented by her mother Keila Robles Figueroa (“Plaintiff” or “Robles”), filed a medical malpractice lawsuit against Dr. Juan C. Castañer (“Castañer”), Presbyterian Community Hospital, Inc. (“the Hospital”) and the Hospital Pediátrico Universitario (collectively “Defendants”). The allegations of negligence in this lawsuit are centered on the medical care providers’ treatment of Robles and her baby during her pregnancy, delivery, and the neonatal care of her premature infant. Robles claimed that the Defendants deviated from the established standards of care.

    Defendants sought to exclude the testimony of Plaintiff’s life care planning expert witness, Jocelyn Holt.

    Life Care Planning Expert Witness

    Jocelyn Holt is a certified life care planner since 2017. She is also a Licensed Occupational Therapist in the states of Florida and North Carolina. She holds  a bachelor’s degree in Science, occupational therapy with a minor in Health Science Education from the University of Florida. In addition, she holds a Life Care Planning Certification Course from the Institute of Rehabilitation Education and Training. Her experience since 2002 has been mainly as an Occupational Therapist, yet since 2018 she is the owner of and life care planner at Planning Hope, LLC in Gainesville, Florida. 

    Want to know more about the challenges Jocelyn Holt has faced? Get the full details with our Challenge Study report.

    Discussion by the Court

    Defendant’s Arguments

    According to Defendants, Holt’s limited experience with pediatric patients, particularly infants and children with complex medical conditions like autism and brain injury, and her inexperience in preparing a life care plan for a medical malpractice case is a significant factor in disqualifying her testimony. They added that Holt did not collaborate with or consult any medical experts, including neurologists, pediatricians, or other relevant specialists, before rendering her life care plan. Specifically, they maintained that she prepared her life care plan without consulting any of Kamila’s treating physicians. In addition, Defendants argued that since Holt relied on generalized data from the Center for Disease Control and Prevention (“CDC”) as to life expectancy— that is not specific to Kamila’s condition— and did not consult appropriate experts, her testimony does not meet the Daubert standards because it lacked a reliable foundation. Defendants also questioned Holt’s methodology and conclusions as speculative and unreliable.

    Plaintiff’s Arguments

    In response, Plaintiff submitted that the motion in limine constitutes an untimely dispositive motion disguised as a motion in limine. To this extent, Plaintiff argued that this District has already held that “a motion in limine to exclude the Plaintiff’s expert on grounds that his opinion is unreliable was not the appropriate tool to move for judgment on a particular claim.”

    She argued that “an expert witness may base his opinion on reports, writings or observations not in evidence which were made or compiled by others, so long as they are of a type reasonably relied upon by experts in that particular field.”

    Analysis

    A. Holt’s Qualifications

    Based on her credentials and extensive experience, the Court determined that Holt was qualified to testify as a life care planner.

    B. Holt’s Life Care Plan for Keila Robles on behalf of Kamila Robles (“Life Care Plan Report”)

    Holt’s life care plan report, dated April 18, 2023, indicates that “the recommendations are gathered from information provided by [Kamila’s] medical providers through records and evaluations, Keila Robles, evidenced [sic] base practices, as well as knowledge/experience from this life care planner.”

    Moreover, during her deposition, Holt admitted that she did not consult any physician before she rendered the life care plan report. She also stated that the life care plan reflects her opinion, based on her assessment after speaking with Kamila’s mother and reviewing her medical record. To this extent she expressed that she interviewed Kamila’s mother on two different occasions. 

    Holt used the National Vital Statistic Reports and CDC data and indicated she was not an expert in life expectancy. To that extent, in her life care plan Report, Holt clearly stated that “opinions on the life expectancy tables are deferred to an appropriate expert.”

    In addition, in page 15 of her life care plan report, Holt listed a series of references used to prepare her report, which included various website links including the CDC and other publications from the pediatric and medical field.

    Foremost, and Plaintiff admitted as much, Holt will only testify as a life care planner, and not as to the applicable medical standards of care; the departures from the medical standards of care by Defendants in the treatment of Kamila; or the causal relationship between the alleged departure from the medical standards of care with Kamila’s damages. 

    Reliability and Methodology

    While Defendants questioned the reliability of Holt’s life care plan because she did not consult Kamila’s physicians and attacked Holt’s conclusion because of her methodology and basis, the Court noted that in the first few pages of his report, Holt employed the standard methodology applied by life care planners which requires consideration of: (a) available medical records; (b) assessment of the individual; (c) assessment of the data and the individual’s needs, and (d) research of the costs within the relevant geographical area of items needed for the proper care of the patient. This appeared to be a sufficiently reasonable and reliable method for formulating a life-care plan.

    The Court agreed with the Defendants to the extent that there might be some deficiencies in the strength of support for some of the recommendations in Holt’s life care plan report, but concluded that those issues go to the weight, and not the admissibility, of Holt’s testimony. Holt will be able to testify, and be subject to cross-examination, about her opinions in this case. 

    Held

    The Court denied the Defendant’s motion in limine to exclude the testimony of Plaintiff’s life care planning expert witness, Jocelyn Holt.

    Key Takeaway:

    Despite challenges to Holt’s qualifications, the Court determined she was qualified to testify, given her extensive experience as a certified life care planner and licensed occupational therapist. Defendants argued that Holt’s failure to consult Kamila’s treating physicians and her reliance on generalized data from the CDC rendered her testimony unreliable. However, the Court noted that life care planners are not required to consult with treating physicians when formulating life care plans. Furthermore, the Court found Holt’s methodology to be reasonable and consistent with standard practices in the field. While the Defendants raised valid concerns about the strength of some of Holt’s conclusions, the Court concluded that these issues affected the weight of her testimony, not its admissibility. As a result, Holt was allowed to testify, and the Court permitted cross-examination regarding her opinions.

    Case Details:

    Case Caption: Robles-Figueroa V. Presbyterian Community Hospital, Inc. Et Al
    Doket Number: 3:22cv1361
    Court: United States District Court for the District of Puerto Rico
    Order Date: January 27, 2025

  • Internal Medicine Expert Witnesses Barred from Testifying Due to Procedural Violations

    Internal Medicine Expert Witnesses Barred from Testifying Due to Procedural Violations

    On October 10, 2023, Kathleen Loveall (Plaintiff) initiated this wrongful death action on behalf of her husband, James Loveall, naming the Government as a defendant under the Federal Tort Claims Act. The Court established September 23, 2024, as the deadline for Loveall’s expert designations. Loveall requested extensions of this deadline three times, without opposition from the Government, and the Court granted each request. The final deadline for expert designations was set for November 13, 2024.

    On that date, Loveall designated Rajesh Bhagat, M.D., and Christopher Bourean, M.D., as an expert witnesses. The Government subsequently moved to strike these expert designations, asserting noncompliance with the expert designation requirements of Federal Rule of Civil Procedure 26(a). Loveall did not file a response, and the time to do so has expired.

    Internal Medicine Expert Witnesses

    Rajesh Bhagat

    Dr. Rajesh Bhagat graduated from University College of Medical Sciences, University of Delhi, India (1983). After two years as an intern and houseman at Safdarjang Hospital, Delhi, he joined Vallabhbhai Patel Chest Institute (VPCI), University of Delhi. As a PGY 1-3, he graduated with a Diploma and an MD in Respiratory Diseases with honors. He served another three years as a Registrar at the same institution, where his research interests included ABPA and Asthma. This research led him to Dr. Cockcroft at the Royal University Hospital in Saskatoon, Canada. As a Research Fellow of the Saskatchewan Lung Association, he worked on the detrimental effects of regular use of beta-2 agonists (1993-1995). These studies were cited in the NIH National Asthma Education and Prevention Program-2.

    After three years of residency in Internal Medicine at the University of Missouri-Columbia (1995-1998), he worked as a fellow in Pulmonary & Critical Care Medicine at Duke University Medical Center, NC (1998-2002). At Duke, he conducted research on lung injury and fibrosis. Since 2002, at UMMC and the VA in Jackson, he has enjoyed being a clinician, administrator, teacher, and researcher. His current focus is paraquat-induced lung injury, as well as mentoring and advising fellows and faculty.

    Get the full story on challenges to Rajesh Bhagat’s expert opinions and testimony with an in-depth Challenge Study.   

    Christopher Bourean

    Dr. Christopher Michael Bourean specializes in hospital-based internal medicine. In April 2019, Bourean served as a resident at the G.V. (Sonny) Montgomery VA Medical Center (“VAMC”) in Jackson, Mississippi, where he gained valuable clinical experience.

    Want to know more about the challenges Christopher Bourean has faced? Get the full details with our Challenge Study report.   

    Discussion by the Court

    i. Defendant’s Arguments 

    The Government asked this Court to strike Loveall’s expert designations of Bhagat and Bourean as inadequate under both Rule 26(a)(2)(B) and Rule 26(a)(2)(C). Loveall’s designations state that Bhagat and Bourean’s expected testimony will be based on, among other things, their “treatment of the plaintiff and review of the medical records.” However, no written reports have been submitted for either physician, precluding compliance with Rule 26(a)(2)(B). Additionally, both Bhagat and Bourean executed declarations contradicting the opinions Loveall attributed to them, further undermining her designations. That Loveall’s designated experts are treating physicians does not excuse her from the obligation to properly disclose their opinions and the facts and data that form the bases of those opinions.

    ii. Analysis

    Even if a report were not required, Loveall’s designations fail to meet the standards of Rule 26(a)(2)(C). While Loveall sufficiently identified the subject matter of the witnesses’ testimony—critical care medicine for Bhagat and hospital-based internal medicine for Bourean—her disclosures do not satisfy the second prong of Rule 26(a)(2)(C). Specifically, Loveall expects both physicians to testify that the cause of death was acute respiratory failure likely due to pulmonary embolism, but she has provided no explanation of facts to support these opinions. Proper disclosure requires a clear and detailed explanation of the facts, data, and opinions to allow the opposing party to prepare rebuttal testimony. Instead, Loveall’s designations merely restate allegations from her complaint, rendering them insufficient under Rule 26(a)(2)(C).

    The Court also found that striking the expert designations was an appropriate remedy. While Loveall identified the witnesses, her deficient disclosures and failure to properly comply with applicable rules warrant enforcement of local rules and scheduling orders. The testimony of Bhagat and Bourean is crucial to Loveall’s case, underscoring the importance of compliance with deadlines. The Government has demonstrated prejudice arising from continued delays, which impedes its ability to prepare for trial. Furthermore, the Court finds no reason to believe that a continuance would cure the deficient designations due to Loveall’s repeated extensions and her failure to respond to the Government’s motion. Because at least three of the four factors weigh in the Government’s favor, the Court finds striking Loveall’s designations is an appropriate remedy.

    Held

    The Court held that Loveall failed to comply with Federal Rule of Civil Procedure 26(a) and Local Uniform Civil Rule 26(a). It granted the Government’s motion to strike Loveall’s expert designations as unopposed under Local Rule 7(b)(3)(E) and found the Government’s arguments independently persuasive. Accordingly, the Government’s motion against Rajesh Bhagat and Christopher Bourean was granted.

    Key Takeaway:

    When deciding whether striking an expert witness is appropriate for such a failure, the Court considers four factors to determine if the failure was substantially justified or harmless: (1) the explanation for the failure to identify the witness, (2) the importance of the testimony, (3) the potential prejudice in allowing the testimony, and (4) the availability of a continuance to cure that prejudice.

    Applying these factors, the Court found that Loveall failed to identify the witnesses properly. The Government demonstrated potential prejudice in its ability to prepare for trial if the testimony were allowed. The Court also determined that a continuance would not cure the deficiencies. This was especially true given Loveall’s repeated extensions and failure to act.

    Case Details:

    Case Caption: Kathleen Loveall V. United States Of America
    Docket Number: 3:23cv2998
    Court: United States District Court for the Southern District of Mississippi, Northern Division
    Order Date: December 31, 2024